His primary areas of study are Rheumatoid arthritis, Internal medicine, Arthritis, Physical therapy and Rheumatology. His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Clinical trial, Surgery, Rheumatism, Immunopathology and Severity of illness. His Adalimumab, Autoimmune disease and Erythrocyte sedimentation rate study in the realm of Internal medicine interacts with subjects such as Sulfasalazine.
His Arthritis study combines topics from a wide range of disciplines, such as Prospective cohort study, Pathology, Infliximab and C-reactive protein. His work in the fields of Physical therapy, such as Physical exercise, overlaps with other areas such as In patient. As a member of one scientific family, he mostly works in the field of Rheumatology, focusing on Disease activity and, on occasion, Descriptive statistics.
P.L.C.M. van Riel mainly investigates Rheumatoid arthritis, Internal medicine, Physical therapy, Arthritis and Surgery. His Rheumatoid arthritis research includes elements of Prospective cohort study and Autoimmune disease, Disease. P.L.C.M. van Riel studied Internal medicine and Gastroenterology that intersect with Adalimumab.
His biological study spans a wide range of topics, including Psychological intervention, Epidemiology, Randomized controlled trial, Alternative medicine and Construct validity. He usually deals with Arthritis and limits it to topics linked to Severity of illness and Cohort study. His Surgery research is multidisciplinary, incorporating perspectives in Placebo, Adverse effect and Rheumatoid factor.
P.L.C.M. van Riel focuses on Rheumatoid arthritis, Internal medicine, Physical therapy, In patient and Disease. P.L.C.M. van Riel interconnects Psoriasis, Cohort study, Arthritis, Randomized controlled trial and Cohort in the investigation of issues within Rheumatoid arthritis. His research in Arthritis intersects with topics in Prospective cohort study, Scleroderma, Pathology and Wrist.
His studies link Surgery with Internal medicine. P.L.C.M. van Riel combines subjects such as Outpatient clinic, Psychosocial, Cross-sectional study, Cognition and Severity of illness with his study of Physical therapy. His studies in Disease integrate themes in fields like Single-nucleotide polymorphism, Blood pressure and Dutch Population.
His primary areas of investigation include Rheumatoid arthritis, Physical therapy, Internal medicine, In patient and Arthritis. The concepts of his Rheumatoid arthritis study are interwoven with issues in Disease activity, Cohort study, Randomized controlled trial, Cohort and Risk factor. His work deals with themes such as Cross-sectional study, Receiver operating characteristic, Severity of illness and Confidence interval, which intersect with Physical therapy.
His Internal medicine study focuses mostly on Discontinuation, Clinical trial, Case-control study, Rheumatology and Exacerbation. His research integrates issues of Range of motion, Observational study and Predictive value of tests in his study of Clinical trial. He has researched Arthritis in several fields, including Psoriasis, Prospective cohort study, Pathology and Lupus erythematosus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Modified disease activity scores that include twenty-eight-joint counts : development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
M.L.L. Prevoo;M.A. van 't Hof;H.H. Kuper;M.A. van Leeuwen.
Arthritis & Rheumatism (1995)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados.
Revmatologiia (2011)
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria
A.M. van Gestel;M.L.L. Prevoo;M.A. van 't Hof;M.H. van Rijswijk.
Arthritis & Rheumatism (1996)
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
D M van der Heijde;M A van 't Hof;P L van Riel;L A Theunisse.
Annals of the Rheumatic Diseases (1990)
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
J.S. Smolen;F.C. Breedveld;M.H. Schiff;J.R. Kalden.
Rheumatology (2003)
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.
E.J.A. Kroot;B.A.W. de Jong;M.A. van Leeuwen;H.L. Swinkels.
Arthritis & Rheumatism (2000)
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
A.M. van Gestel;C.J. Haagsma;P.L.C.M. van Riel.
Arthritis & Rheumatism (1998)
The Disease Activity Score and the EULAR response criteria.
J. Fransen;P.L.C.M. van Riel.
Clinical and Experimental Rheumatology (2005)
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
L B A van de Putte;C Atkins;M Malaise;J Sany.
Annals of the Rheumatic Diseases (2004)
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
G. Wells;J.C. Becker;J. Teng;M. Dougados.
Annals of the Rheumatic Diseases (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Radboud University Nijmegen
Radboud University Nijmegen Medical Centre
University of Leeds
Leiden University
Radboud University Nijmegen
Hôpital Cochin
Vrije Universiteit Amsterdam
Dudley Group NHS Foundation Trust
Leiden University Medical Center
University of Amsterdam
Zhejiang University
Microsoft (United States)
The University of Texas at Austin
Humboldt-Universität zu Berlin
Deakin University
University of California, Los Angeles
Roma Tre University
University of California, Davis
Louisiana State University
GEOMAR Helmholtz Centre for Ocean Research Kiel
University of Paris-Saclay
University of Cambridge
Sorbonne University
University of Connecticut
University of Technology Sydney
MIT